Use access key #2 to skip to page content.
$38.77 -2.18 (-5.32%)
7/23/2008 4:00 PM

Pharmaceutical Product Development, Inc. (PPDI)

CAPS Rating:
*****

The Company is a global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PPDI

Add Stock to Watchlist

What the Community Thinks

Total Members

247 Outperforms
5 Underperforms
 

All-Stars

75 Outperforms
1 Underperforms
 

Wall Street

8 Outperforms
0 Underperforms
 

Members bullish on PPDI are also bullish on:

Members bearish on PPDI are also bearish on:

Ticker Tags

Mid Cap (670), Medical Laboratories & Research (22), Contract Research Services (2), Research (14)
Suggest a tag

Pharmaceutical Product Development, Inc. At A Glance

Current Price: $38.77
Last Trade Time: 7/23/2008 4:00 PM
Open: $0.00
Previous Close: $40.95
Daily Range: $36.54 - $39.45
52-Week Range: $33.03 - $49.39
Volume: 3,640,127
Market Cap: $4.90B
P/E Ratio: 29.04
Compare Our Special Broker Offers!

Stock Trends

PPDI VS S&P 500 (SPY)

PPDI 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for PPDI

More Headlines...

Top Bull Pitch

Recs

1

Pharmaceutical Product Development, Inc. (PPDI)

Avatar dustbusterz (86.32) Submitted: 10/02/07 4:08 PM

with a clean balance sheet, nice r.o.e. and growing earnings.i see no reason this one cannot give back a little share uptick.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Pharmaceutical Product Development, Inc. (PPDI)

Avatar dexion10 (20.65) Submitted: 10/25/07 10:32 AM

The biz model of developing drugs internally will prove to be a drag on this company - the drugs they buy are drugs that other pharmas didn't want... for example their Statin drug and diabetes candidates are also rans.... nothing exceptional.

Worse their statin will hit the market after Lipitor is...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 25 :   1 2 3 4 5 Next »

Recs

0

 (PPDI)

Avatar ongkaili (< 20) Submitted: 7/19/08 7:33 AM : Outperform Start Price: $39.84 PPDI Score: -4.09

beaten senseless for no reason

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PPDI)

Avatar ResearchLover (96.51) Submitted: 6/14/08 12:57 PM : Outperform Start Price: $42.97 PPDI Score: -3.84

This CRO/drug development service firm looks like a strong growth company, like the whole sector. Compare to CRL, WX (China)...





Negative/timing: A bit volatile, though, so it's one I'd plan on holding a year or more, or look for technical entry points better than this, my virtual entry timing intended on keeping track of a company I had forgotten about in my IRL IRA.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PPDI)

Avatar gman232001 (58.59) Submitted: 4/30/08 9:02 AM : Outperform Start Price: $41.43 PPDI Score: 1.69

Reasonable price for stock, future need for products at an increasing rate.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PPDI)

Avatar ChelseaBee (< 20) Submitted: 4/24/08 9:29 AM : Outperform Start Price: $42.95 PPDI Score: -3.28

With all the drugs--sorry, medications--we all take, how can this stock not be hot!!!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PPDI)

Avatar 082255lmp (< 20) Submitted: 4/24/08 7:57 AM : Outperform Start Price: $42.95 PPDI Score: -3.28

Every one needs drugs. It is human nature.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 25 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 8 of 8  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLadenburg 91.57 07/02/08 Outperform NS $42.66-9.12%-0.57%-8.55
TrackLehmanBros 87.88 01/08/08 01/08/08 Outperform NS $44.42-12.73%-10.20%-2.52
TrackEveillard 93.14 09/30/07 09/30/07 Outperform NS $35.19+10.16%-15.97%+26.13 Toggle the visibility of 60-Second Pitch and replies
TrackWhitman 47.83 09/30/07 09/30/07 Outperform NS $35.19+10.16%-15.97%+26.13 Toggle the visibility of 60-Second Pitch and replies
TrackBofASec 96.35 11/03/06 11/03/06 Outperform NS $31.25+24.07%-6.60%+30.67
TrackBearStearns 90.67 10/17/06 10/17/06 Outperform NS $35.26+9.96%-5.96%+15.92
TrackUBS 94.11 10/06/06 10/06/06 Outperform NS $34.79+11.43%-4.94%+16.37
TrackJimCramer 81.15 04/21/06 04/21/06 Outperform 3W $36.59+5.97%-2.63%+8.60

Results 1 - 8 of 8  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners